Based treatment algorithm for essencial hypertension with olmesartan medoxomil

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• National and international guidelines highlight the need for effective arterial hypertension treatment.
• Despite recommendations, suboptimal blood pressure control and goal attainment persist, necessitating improved therapeutic strategies.

Purpose of the Study:

• To assess the efficacy of a treatment algorithm centered on olmesartan medoxomil for managing arterial hypertension.

Main Methods:

• A prospective, multicenter study involved 144 patients with stage 1 and 2 primary arterial hypertension.
• Olmesartan medoxomil was administered in a four-phase algorithm: monotherapy, combination with hydrochlorothiazide, and addition of amlodipine besylate.
• Patients were either treatment-naïve or underwent a washout period before enrollment.

Main Results:

• 86% of participants achieved the target blood pressure of <130/85 mmHg by the study's end.
• Significant reductions in systolic and diastolic blood pressure were observed, with maximum decreases of -44.4 mmHg and -20.0 mmHg, respectively.
• Systolic and diastolic response rates were high, at 87.5% and 92.4%, respectively.

Conclusions:

• The olmesartan medoxomil-based treatment algorithm, mirroring clinical practice, proved effective for hypertension management.
• This regimen, including monotherapy and combinations with hydrochlorothiazide and amlodipine, successfully helped patients reach recommended blood pressure goals.